Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.
about
Cytotoxic CD4 T cells in antiviral immunityMHC Class II-Restricted Epitopes Containing an Oxidoreductase Activity Prompt CD4(+) T Cells with Apoptosis-Inducing PropertiesAdoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized miceImmunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapyA single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirusUrea-mediated cross-presentation of soluble Epstein-Barr virus BZLF1 protein.Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disordersDendritic cells during Epstein Barr virus infection.Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challengeEpstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for Fas and perforin.The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersIncreased synapse formation obtained by T cell epitopes containing a CxxC motif in flanking residues convert CD4+ T cells into cytolytic effectors.Persistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations.Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding.Epstein-barr virus vaccines.Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes.Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach.Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.Macroautophagy Proteins Assist Epstein Barr Virus Production and Get Incorporated Into the Virus Particles.Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination.Virus-specific CD4+ T cells: ready for direct attack.A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein.Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.Immune escape by Epstein-Barr virus associated malignancies.CD4 memory T cells: what are they and what can they do?Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection.Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.The surprising kinetics of the T cell response to live antigenic cells.Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.Prospects of a novel vaccination strategy for human gamma-herpesviruses.T cell immunity in acute HIV-1 infection.Immunotherapy for EBV-associated malignancies.Burkitt lymphoma: the role of Epstein-Barr virus revisited.Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities.
P2860
Q21296742-D7215FE6-44DD-4428-8E5A-A61854CEB741Q26782899-22C9C407-58BF-4CD8-8347-366A4E34179CQ27324235-4747A79B-45EC-49F4-BF74-D316D353A5CFQ33289956-56D4061B-1699-4FEE-B99C-0C2A763825BDQ33375032-7B561499-2708-4F84-A323-396E963AF9DEQ33383239-55FD6C38-E7C4-4EB6-B3AF-BF8FD9309DE8Q33650689-3EB68E3F-C675-4C4F-809F-08D2DB2D0776Q33782152-112042F8-0CE9-4E27-97F0-510F3C8FDA2FQ34058118-D20B34E9-15B4-4EBB-9D97-4B6B5747DA40Q34116845-183A2ADE-AF81-431B-84FB-0034E0AD3276Q34128024-A2611962-0643-4157-9617-FDB2854E7A59Q34166602-54E6270B-6E1A-4FC5-8B5E-57B96FCC6273Q34440919-895DD125-0F51-4156-8DFA-9C2985529E83Q34602196-3E527F30-8D06-46CF-8F29-7AE139D27F49Q34613494-8D30AB62-CC5E-4A09-B2AF-4800C5A8F1E0Q35053650-9BC6CDF2-5284-4158-8A06-3CC93684268BQ35101353-CCBC3528-6278-4B65-A335-C334E6F23CC6Q35139240-7DDC5A5B-1BB1-4460-8DBB-BEC41609973EQ35140402-FC50EA1F-6098-4FA9-BDC5-AAC3E3B326ADQ35688231-4D88609E-3A81-4F0C-BF35-B8A913497492Q35994831-30D248A3-F3A7-4246-9764-E005095E4F2DQ36228485-77013ED4-DEFF-4F51-B2A8-88ECD9441AAAQ36315473-70E0D10B-00A7-4528-8A29-3E1F9B8987A1Q36641746-99074271-BB64-4956-B6C2-1A668BCDB8B3Q36835091-48724F18-9137-48EF-B4D2-B4EC89A87592Q37041507-6DC97444-0063-4349-9DC0-83198BE29FD4Q37186068-975DABAD-451E-48B3-BBB1-4617B6F0FBF2Q37206430-9DF5A314-FF1C-4915-9A5B-23F7B7125B78Q37272108-E3125852-5455-46CC-8C6B-B66E4CDBAB72Q37418542-32D728E6-049C-4157-8C51-A036312919AAQ37597931-C7B07041-56F1-4B10-9EC7-F35F64C2113DQ37667998-D0AC6A31-08F7-4F7C-A2C2-99757E0D0B03Q37710793-A0127412-2DB2-4EF9-9D26-F35AE7062960Q37773234-36B4DADE-E878-4438-BABD-A05359960D5EQ37780705-266F7233-7AFE-422D-BF2F-6CAE2C55D214Q37789345-ECC10A7B-378C-4C72-93D1-AF84377E7789Q37845178-587A2A33-CE0B-4F14-B4D9-0CABC70DC7D8Q38000577-38E6A2B2-8F13-468C-B7C6-60D80641AE09Q38046606-BE174BE3-603E-4F1A-9AC3-575F0A9913E8Q39170011-1B79D211-3AA3-4EE3-9DD8-BA61E0B625D3
P2860
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Control of Epstein-Barr virus ...... ific for virion glycoproteins.
@ast
Control of Epstein-Barr virus ...... ific for virion glycoproteins.
@en
type
label
Control of Epstein-Barr virus ...... ific for virion glycoproteins.
@ast
Control of Epstein-Barr virus ...... ific for virion glycoproteins.
@en
prefLabel
Control of Epstein-Barr virus ...... ific for virion glycoproteins.
@ast
Control of Epstein-Barr virus ...... ific for virion glycoproteins.
@en
P2093
P2860
P50
P356
P1476
Control of Epstein-Barr virus ...... cific for virion glycoproteins
@en
P2093
Dinesh Adhikary
Klaus Witter
Uta Behrends
P2860
P304
P356
10.1084/JEM.20051287
P407
P577
2006-03-20T00:00:00Z